Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Personalis, Inc. United States | 1 | 413 |
|
Tempus AI - RTP United States | 2 | 647 |
|
Hereditary Cancer Screening - Full Hereditary Cancer Panel (99 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 109 | 99 |
|
RUNX1 Gene Platelet disorder with associated myeloid malignancy NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
RUNX1 Gene Leukemia, acute myeloid NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
PlateletGenex Thrombocytopenia Panel (26 genes) (2 Day STAT TAT) Machaon Diagnostics United States | 22 | 26 |
|
Foundation Medicine, Inc. United States | 2 | 405 |
|
Pittsburgh Cytogenetics Laboratory University of Pittsburgh Medical Center United States | 2 | 70 |
|
Familial Platelet Disorder with Propensity to Acute Myelogenous Leukemia Genetic Pathology SA Pathology Australia | 1 | 1 |
|
Myeloid Next Generation Sequencing with Reflex Pathology Interp Sentara Healthcare Laboratory Services United States | 3 | 69 |
|
UCSF Molecular Diagnostics Laboratory University of California, San Francisco United States | 1 | 52 |
|
OncoAlly™ Comprehensive Hereditary Cancer Analysis Variantyx, Inc. United States | 1 | 88 |
|
Comprehensive HemeComplete Profile + Heme Fusion + CALR PCR + FLT3 PCR PathGroup United States | 16 | 160 |
|
UCSF Molecular Diagnostics Laboratory UCSF Molecular Diagnostics Laboratory University of California, San Francisco United States | 4 | 52 |
|
Centogene AG - the Rare Disease Company Germany | 155 | 107 |
|
Centogene AG - the Rare Disease Company Germany | 74 | 34 |
|
RUNX1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 110 | 112 |
|
Bone Marrow Failure / Anemia Panel Centogene AG - the Rare Disease Company Germany | 212 | 212 |
|
Invitae Multi-Cancer + RNA Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 142 | 63 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.